37496 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 07
19:10 UTC
|
MHC.UN
Flagship Communities Real Estate Investment Trust
|
◎ Target | firm only | Strong-Buy | C$25.00→ C$25.25+1.0% |
|
Oct 07
19:10 UTC
|
MFI
Maple Leaf Foods
|
◎ Target | firm only | Buy | C$39.00→ C$36.00-7.7% |
|
Oct 07
19:10 UTC
|
MET
MetLife
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $112.00→ $109.00-2.7% |
|
Oct 07
19:10 UTC
|
MEDP
Medpace
|
◎ Target | Ann Hynes ★★★★☆ #358 | Outperform | $665.00→ $700.00+5.3% |
|
Oct 07
19:10 UTC
|
LNC
Lincoln National
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $53.00→ $49.00-7.5% |
|
Oct 07
19:10 UTC
|
IQV
IQVIA
|
◎ Target | Ann Hynes ★★★★☆ #358 | Outperform | $275.00→ $300.00+9.1% |
|
Oct 07
19:10 UTC
|
IFC
Intact Financial
|
◎ Target | firm only | Sec→ r Outperform | C$325.00→ C$315.00-3.1% |
|
Oct 07
19:10 UTC
|
HIG
The Hartford Insurance Group
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Neutral | $154.00→ $144.00-6.5% |
|
Oct 07
19:10 UTC
|
FLO
Flowers Foods
|
◎ Target | Max Gumport ★★★★☆ #835 | Underperform | $6.50→ $5.00-23.1% |
|
Oct 07
19:10 UTC
|
EQH
Equitable
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $67.00→ $66.00-1.5% |
|
Oct 07
19:10 UTC
|
ENVA
Enova International
|
◎ Target | John Hecht ★★★☆☆ #2138 | Buy | $300.00→ $275.00-8.3% |
|
Oct 07
19:10 UTC
|
EMA
Emera
|
◎ Target | firm only | Buy | C$79.00→ C$75.00-5.1% |
|
Oct 07
19:10 UTC
|
EG
Everest Group
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Neutral | $416.00→ $398.00-4.3% |
|
Oct 07
19:10 UTC
|
DFY
Definity Financial
|
◎ Target | firm only | Sec→ r Perform | C$84.00→ C$83.00-1.2% |
|
Oct 07
19:10 UTC
|
CU
Canadian Utilities
|
◎ Target | firm only | Buy | C$52.00→ C$57.00+9.6% |
|
Oct 07
19:10 UTC
|
CRBG
Corebridge Financial
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $38.00→ $40.00+5.3% |
|
Oct 07
19:10 UTC
|
CP
Canadian Pacific Kansas City
|
◎ Target | Ariel Rosa ★★☆☆☆ #2573 | Buy | $109.00→ $102.00-6.4% |
|
Oct 07
19:10 UTC
|
CNI
Canadian National Railway
|
◎ Target | Ariel Rosa ★★☆☆☆ #2573 | Buy | $151.00→ $143.00-5.3% |
|
Oct 07
19:10 UTC
|
CIA
Champion Iron
|
◎ Target | firm only | Outperform | C$6.25→ C$5.75-8.0% |
|
Oct 07
19:10 UTC
|
CCA
Cogeco Communications
|
◎ Target | firm only | Hold | C$68.00→ C$64.00-5.9% |
|
Oct 07
19:10 UTC
|
BYD
Boyd Gaming
|
◎ Target | Ben Chaiken not yet tracked | Outperform | $104.00→ $102.00-1.9% |
|
Oct 07
19:10 UTC
|
BCE
BCE
|
◎ Target | firm only | Buy | C$43.00→ C$41.00-4.7% |
|
Oct 07
19:10 UTC
|
BAH
Booz Allen Hamilton
|
◎ Target | Howard Rubel not yet tracked | Hold | $80.00→ $75.00-6.2% |
|
Oct 07
19:10 UTC
|
AVBP
ArriVent BioPharma
|
◎ Target | Soumit Roy not yet tracked | Buy | $45.00→ $22.00-51.1% |
|
Oct 07
19:10 UTC
|
ALL
Allstate
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $300.00→ $295.00-1.7% |
|
Oct 07
18:10 UTC
|
ZYME
Zymeworks
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $32.00→ $34.00+6.2% |
|
Oct 07
18:10 UTC
|
XPO
XPO
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Buy | $240.00→ $220.00-8.3% |
|
Oct 07
18:10 UTC
|
VKTX
Viking Therapeutics
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $87.00→ $85.00-2.3% |
|
Oct 07
18:10 UTC
|
UPS
United Parcel Service
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Buy | $130.00→ $115.00-11.5% |
|
Oct 07
18:10 UTC
|
SM
SM Energy
|
◎ Target | Gabe Daoud not yet tracked | Buy | $43.00→ $48.00+11.6% |
|
Oct 07
18:10 UTC
|
RXO
RXO
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Buy | $28.00→ $30.00+7.1% |
|
Oct 07
18:10 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $239.00→ $240.00+0.4% |
|
Oct 07
18:10 UTC
|
REGN
Regeneron Pharmaceuticals
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $772.00→ $780.00+1.0% |
|
Oct 07
18:10 UTC
|
RCKT
Rocket Pharmaceuticals
|
◎ Target | Roanna Ruiz ★★★★☆ #675 | Market Perform | $7.00→ $4.00-42.9% |
|
Oct 07
18:10 UTC
|
PCRX
Pacira BioSciences
|
◎ Target | Les Sulewski ★★★★☆ #617 | Buy | $30.00→ $31.00+3.3% |
|
Oct 07
18:10 UTC
|
OABI
OmniAb
|
◎ Target | Puneet Souda ★★★★★ #52 | Outperform | $10.00→ $12.00+20.0% |
|
Oct 07
18:10 UTC
|
CB
Chubb
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Neutral | $347.00→ $336.00-3.2% |
|
Oct 07
18:10 UTC
|
BRO
Brown & Brown
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $83.00→ $78.00-6.0% |
|
Oct 07
18:10 UTC
|
AXS
Axis Capital
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $118.00→ $116.00-1.7% |
|
Oct 07
18:10 UTC
|
AON
AON
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $366.00→ $324.00-11.5% |
|
Oct 07
18:10 UTC
|
AJG
Arthur J. Gallagher & Co.
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Outperform | $292.00→ $271.00-7.2% |
|
Oct 07
18:10 UTC
|
AIG
American International Group
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Neutral | $85.00→ $83.00-2.4% |
|
Oct 07
18:10 UTC
|
AFL
Aflac
|
◎ Target | Yaron Kinar ★★★☆☆ #1956 | Underperform | $116.00→ $107.00-7.8% |
|
Oct 07
17:10 UTC
|
ZS
Zscaler
|
◎ Target | Richard Poland ★★☆☆☆ #2630 | Overweight | $215.00→ $260.00+20.9% |
|
Oct 07
17:10 UTC
|
ZS
Zscaler
|
◎ Target | Patrick Colville ★★★★☆ #587 | Sec→ r Outperform | $240.00→ $255.00+6.2% |
|
Oct 07
17:10 UTC
|
ZS
Zscaler
|
◎ Target | Brian Essex ★★★☆☆ #1679 | Overweight | $215.00→ $245.00+14.0% |
|
Oct 07
17:10 UTC
|
PKG
Packaging Corporation of America
|
◎ Target | Gabe Hajde not yet tracked | Equal Weight | $246.00→ $245.00-0.4% |
|
Oct 07
17:10 UTC
|
PENG
Penguin Solutions
|
◎ Target | Kevin Cassidy ★★★☆☆ #1531 | Buy | $80.00→ $100.00+25.0% |
|
Oct 07
17:10 UTC
|
MRVL
Marvell Technology
|
◎ Target | Aaron Rakers ★★★☆☆ #1618 | Overweight | $310.00→ $365.00+17.7% |
|
Oct 07
17:10 UTC
|
MRVL
Marvell Technology
|
◎ Target | Harlan Sur ★★★☆☆ #1352 | Overweight | $305.00→ $360.00+18.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.